As CD147 can be proteolytically cleaved resulting in a shed form of CD147, we determined serum CD147 and found that serum CD147 levels correlated positively with serum TFF3 levels in the CRC patients (r = 0.228, p = 0.042, Supplementary Table 8). This evidence concerns the gene TFF3 and colorectal carcinoma.